Skip to main content

Lung Cancer Stages

Cancers are staged depending on how far they have spread. Staging a cancer correctly is essential to select the most appropriate treatment option. A number of diagnostic tests, such as CT scans, MRIs, bronchoscopy, blood tests, bone scans, and biopsies are used to find out how far the cancer has spread.

Non-small cell lung cancers, which account for about 80 percent of lung cancers, are staged using the Roman numerals 0 through IV. If a cancer is too small to be detected, it is called an occult or hidden cancer and not assigned any numeral. Stage 0 cancer, or carcinoma in situ, is limited to the lung and only involves a few layers of cells. Stage I cancer is still limited to the lung, with an area of normal tissue surrounding it. Stage I cancers are further divided into Stage IA and Stage IB, depending on the size of the tumor. In stage II cancer, the cancer may have spread to nearby lymph nodes, the chest wall, the diaphragm, or to the tissues lining the lung (pleura) and the heart (pericardium). In stage III cancer, lymph nodes in the central chest or on the other side of the body from the original tumor are involved. Stage III cancer is further divided into stage IIIA and stage IIIB. In stage IV cancer, the cancer has spread to other parts of the body, such as the liver, bones or brain, or to a lobe of the other lung. Cancers that are stages 0 through IIIA may be treated with surgery. Treatment of stage III and stage IV cancers requires chemotherapy and radiotherapy.

Small cell lung cancer has two stages. Limited-stage cancer is limited to only one lung, the tissues between the lungs, and nearby lymph nodes. In extensive-stage small cell lung cancer, the cancer has spread to other parts of the body. The brain is commonly involved in extensive-stage cancer.

Popular posts from this blog

Alternative Pain Therapy for Breast, Prostate and Lung Cancer

Alternative Pain Therapy for Breast, Prostate and Lung Cancer MIAMI--(Healthcare Sales & Marketing Network)-- Bio-Nucleonics? lead product Strontium Chloride Sr-89 Injection USP (Strontium-89), which is the generic version of Metastron?, is an option to consider for metastatic cancer bone pain therapy, typically caused by advanced stage breast, prostate or lung cancer. Strontium Chloride Sr-89 Injection USP (Strontium-89) is a radioactive pharmaceutical injection to relieve bone pain in patients with painful skeletal metastases. In the body, Strontium acts similar to calcium and is preferentially taken up in osteoblastic tissue while the unabsorbed isotope is excreted in the urine the first 2 to 3 days following injection, clearing rapidly from the blood and selectively localizing in bone mineral. Uptake of strontium by bone occurs preferentially in sites of active osteogenesis; thus primary bone tumors and areas of metastatic involvement (blastic lesions) can accumulate significa...

Analysis: Life saving lung cancer test to set off cost debate

By Bill Berkrot NEW YORK | Wed Jun 29, 2011 6:07pm EDT NEW YORK (Reuters) - A landmark study showing that routine lung screening of heavy smokers and former smokers using low dose CT scans could save thousands of lives is sure to set off a fierce debate about the cost of such testing on an overburdened healthcare system. The U.S. National Cancer Institute studied more than 53,000 people between the ages of 55 and 74 deemed at high risk of developing lung cancer. It found that screening with the three-dimensional X-rays cut deaths by 20 percent. Details of the study and a discussion of its implications were published on Wednesday in the New England Journal of Medicine, lending additional weight to initial findings that were released in November. The discussion noted that radiologists using more advanced CT equipment than was available for the study could lead to an even larger reduction in lung cancer deaths. At the same time, the potential for many more false positive results could ri...

What Is Relay For Life About And Why Is It Important?

The Relay for Life idea began with one person wanting to fight cancer. In 1985 Dr. Gordy Klatt decided to run and walk around a track for 24 hours as an effort to raise money for the American Cancer Society. His idea has caught on big time and now more than 3.5 million people take part in the annual Relay for Life in over 5,000 towns and cities in the United States as well as in 20 other countries around the globe. To quote the Relay for Life site, it's a "global phenomenon" and it raises much needed funds as well as a national awareness for cancer and the research into a cure. During this first year Dr. Klatt ran over 83 miles at the University of Puget Sound, Tacoma, Washington. As Dr. Klatt walked and ran his laps family and friends participated by donating $25 to walk and run with him for half an hour. This initial effort by Dr. Klatt produced $27,000 of funds that were put to cancer research to fight this disease. Every Relay For Life has many similarities although ...